A New Hope for Alzheimer's
A recent study on NMN and its potential effects
on Alzheimer's disease is big news for NMN.
In the study, researchers gave NMN to mice with Alzheimer's symptoms
and tested its effects on brain cells.
Here is what you need to know:
Alzheimer's Disease (AD) is a brain disorder that gets worse over time,
mainly affecting older people.
It causes memory loss and thinking problems and builds up abnormal proteins in the brain.
Currently treatments only help with symptoms but don't stop the disease from getting worse.
Nicotinamide Mononucleotide (NMN) is a compound that might help treat Alzheimer's disease by addressing two main problems: damage caused by harmful molecules (oxidative stress) and issues with cell's cleanup process (autophagy dysfunction).
Key Study Findings:
NMN Improves Cognitive Function: NMN treatment in Alzheimer's mice improved their memory and learning abilities.
NMN Protects Neurons: NMN reduces cell damage in the brain regions most affected by Alzheimer's.
NMN Lowers Oxygen-Related Stress: NMN activates the Nrf2/Keap1/NQO1 pathway, which boosts the levels of protective proteins that help shield cells from damage.
NMN Promotes Autophagy: NMN enhances autophagy (cell cleanup), helping clear out the harmful brain proteins accumulating in Alzheimer's.
Take charge of your brain health today!